Please assess the completion status of the following clinical trial:

Trial Title: The Efficacy of Prophylactic Antibiotic Administration During Breast Cancer Surgery in Overweight Patients.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women at any age with early stage breast cancer (stage I-II) and American Society of Anesthesiologists (ASA) score of I-II.~Exclusion Criteria:~* Ductal carcinoma in situ (DCIS; stage 0 cancer),~* Advanced or distant metastatic stage,~* Receiving any neoadjuvant therapy,~* History of receiving any antibiotics within prior 3 months,~* History of immunodeficiency,~* Having a remote infection,~* History of reaction to study antibiotics,~* Denial of signing the consent form.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Prophylaxis Group (Type: ACTIVE_COMPARATOR): patients who are BMI over 25 and receiving ampicillin/sulbactam prophylaxis
- No Prophylaxis Group (Type: NO_INTERVENTION): Patients who are BMI over 25 and do not receive antibiotic prophylaxis

Based on this trial design, predict the completion outcome and termination type (if applicable).